EP1660101A4 - Liquid formulations for the prevention and treatment of mucosal diseases and disorders - Google Patents

Liquid formulations for the prevention and treatment of mucosal diseases and disorders

Info

Publication number
EP1660101A4
EP1660101A4 EP03818749A EP03818749A EP1660101A4 EP 1660101 A4 EP1660101 A4 EP 1660101A4 EP 03818749 A EP03818749 A EP 03818749A EP 03818749 A EP03818749 A EP 03818749A EP 1660101 A4 EP1660101 A4 EP 1660101A4
Authority
EP
European Patent Office
Prior art keywords
disorders
prevention
treatment
liquid formulations
mucosal diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03818749A
Other languages
German (de)
French (fr)
Other versions
EP1660101A1 (en
Inventor
Jeremy E Jacob
David P Nowotnik
Christiane M Baud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abeona Therapeutics Inc
Original Assignee
Access Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Access Pharmaceuticals Inc filed Critical Access Pharmaceuticals Inc
Publication of EP1660101A1 publication Critical patent/EP1660101A1/en
Publication of EP1660101A4 publication Critical patent/EP1660101A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP03818749A 2003-08-21 2003-08-21 Liquid formulations for the prevention and treatment of mucosal diseases and disorders Withdrawn EP1660101A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/026431 WO2005027939A1 (en) 2003-08-21 2003-08-21 Liquid formulations for the prevention and treatment of mucosal diseases and disorders

Publications (2)

Publication Number Publication Date
EP1660101A1 EP1660101A1 (en) 2006-05-31
EP1660101A4 true EP1660101A4 (en) 2010-02-24

Family

ID=34374767

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03818749A Withdrawn EP1660101A4 (en) 2003-08-21 2003-08-21 Liquid formulations for the prevention and treatment of mucosal diseases and disorders

Country Status (5)

Country Link
EP (1) EP1660101A4 (en)
JP (1) JP2007522077A (en)
AU (1) AU2003265624B2 (en)
CA (1) CA2537080A1 (en)
WO (1) WO2005027939A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2661274A1 (en) * 2006-08-29 2008-03-06 University Of Kentucky Research Foundation Compositions and methods for oral cancer chemoprevention using berry preparations and extracts
US20130030009A1 (en) * 2010-12-30 2013-01-31 Ziv Harish Method for the treatment and/or prevention of oral allergic symptions of the lips due to oral contact with a food allergen
US9801885B2 (en) 2011-06-23 2017-10-31 Prokrea Bcn, S.L. Transvaginal phosphodiesterase inhibitors for infertility treatment
ES2395801B1 (en) * 2011-06-23 2014-06-06 María Carmen PARDINA PALLEJÀ "PENTOXIFILINA BY TRANSVAGINAL ROUTE FOR THE TREATMENT OF INFERTILITY"   
US9636360B2 (en) 2012-09-18 2017-05-02 pH Science Holdings, Inc Method and composition for treating gastro-esophageal disorders
EP3046544A4 (en) 2013-09-17 2017-03-22 Terapio Corporation Methods of preventing or treating mucositis using rlip76
CN103751786B (en) * 2014-01-07 2016-01-20 北京欣普迪生物科技有限公司 Be used for the treatment of the compositions of mucosa ulcer
PL3294279T3 (en) * 2015-05-14 2020-06-29 Professional Dietetics International S.R.L. Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
EP3222270A1 (en) * 2016-03-23 2017-09-27 Bionanoplus, S.L. Compositions for mucosal adhesion and uses thereof
WO2020084530A1 (en) * 2018-10-24 2020-04-30 Ferring B.V. Mucoadhesive pharmaceutical compositions of corticosteroids

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
WO1997044021A1 (en) * 1996-05-23 1997-11-27 John Rhodes Pharmaceutical products containing a complex of an amide-type local anesthetic and a polyacrylate
WO1999013862A2 (en) * 1997-09-12 1999-03-25 Columbia Laboratories (Bermuda) Limited A pharmaceutical composition for treating dysmenorrhea and premature labor
WO2002051382A2 (en) * 2000-12-27 2002-07-04 University Of Kentucky Research Foundation Ph-sensitive mucoadhesive film-forming gels and wax-film composites
US20020103219A1 (en) * 2000-10-05 2002-08-01 Jeremy Jacob Stable viscous liquid formulations of amlexanox for the prevention and treatment of mucosal diseases and disorders
WO2002064113A1 (en) * 2001-02-15 2002-08-22 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
WO2003037355A1 (en) * 2001-10-30 2003-05-08 Reckitt Benckiser Healthcare (Uk) Limited Polyacrylate compositions for use in protecting mucosa

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6030646B2 (en) * 1974-10-22 1985-07-17 興和株式会社 Method for stabilizing skin treatment compositions
US5575652A (en) * 1987-01-30 1996-11-19 Colgate Palmolive Company Process for applying antibacterial oral composition to dental implant areas
US5298258A (en) * 1989-12-28 1994-03-29 Nitto Denko Corporation Acrylic oily gel bioadhesive material and acrylic oily gel preparation
GB9101986D0 (en) * 1991-01-30 1991-03-13 Smith & Nephew Pharmaceutical compositions
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
AU7371894A (en) * 1993-07-28 1995-02-28 Insite Vision Incorporated Suspensions for delivery of medicament
JP3456236B2 (en) * 1993-11-05 2003-10-14 ライオン株式会社 Oral gel composition
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
JPH08295637A (en) * 1995-04-27 1996-11-12 Green Cross Corp:The Local administrative agent for oral cavity
US5955097A (en) * 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
ATE304522T1 (en) * 2000-05-04 2005-09-15 Warner Lambert Co METHOD FOR INHIBITING AMYLOID PROTEIN AGGREGATION AND FOR DIAGNOSTIC DETECTION OF AMYLOID DEPOSIT USING AMINOINDANDERIVATES
IT1318649B1 (en) * 2000-07-28 2003-08-27 Propharma S R L Ora Sinclair P PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MUCOSITES AND STOMATITIS.
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
IN191090B (en) * 2000-08-29 2003-09-20 Ranbanx Lab Ltd
JP2003055201A (en) * 2001-08-13 2003-02-26 Lion Corp Solubilized composition containing vitamin a compounds and method for stabilizing vitamin a compounds

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
WO1997044021A1 (en) * 1996-05-23 1997-11-27 John Rhodes Pharmaceutical products containing a complex of an amide-type local anesthetic and a polyacrylate
WO1999013862A2 (en) * 1997-09-12 1999-03-25 Columbia Laboratories (Bermuda) Limited A pharmaceutical composition for treating dysmenorrhea and premature labor
US20020103219A1 (en) * 2000-10-05 2002-08-01 Jeremy Jacob Stable viscous liquid formulations of amlexanox for the prevention and treatment of mucosal diseases and disorders
WO2002051382A2 (en) * 2000-12-27 2002-07-04 University Of Kentucky Research Foundation Ph-sensitive mucoadhesive film-forming gels and wax-film composites
WO2002064113A1 (en) * 2001-02-15 2002-08-22 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
WO2003037355A1 (en) * 2001-10-30 2003-05-08 Reckitt Benckiser Healthcare (Uk) Limited Polyacrylate compositions for use in protecting mucosa

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2005027939A1 *

Also Published As

Publication number Publication date
AU2003265624B2 (en) 2011-03-31
AU2003265624A1 (en) 2005-04-11
JP2007522077A (en) 2007-08-09
CA2537080A1 (en) 2005-03-31
WO2005027939A1 (en) 2005-03-31
EP1660101A1 (en) 2006-05-31

Similar Documents

Publication Publication Date Title
EP1737453A4 (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders
IL175425A0 (en) Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders
PT1644021E (en) Methods and compositions for the treatment of gastrointestinal disorders
IL160389A0 (en) Use of flibanserin for the treatment of sexual disorders
IL169338A0 (en) Therapeutic formulations for the treatment of beta-amyloid related diseases
GB0404693D0 (en) Pharmaceutical preparations for the treatment of ocular surface and other disorders
AU2003286567A8 (en) Methods for the treatment of skin disorders
AU2002252373A1 (en) Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
PL378108A1 (en) Combination therapy for the treatment of immunoinflammatory disorders
EP1680145A4 (en) Methods and compositions for the treatment of neurological disease
IL175412A0 (en) Use of specific histones for the treatment of parasitic diseases
AU2003293099A8 (en) Treatment of dna damage related disorders
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
PL1670482T5 (en) Use of ciclesonide for the treatment of respiratory diseases
EP1660101A4 (en) Liquid formulations for the prevention and treatment of mucosal diseases and disorders
AU2003209150A8 (en) Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
IL175426A0 (en) Methods of using and compositions comprising pde4 modulators for the treatment and management of asbestos-related diseases and disorders
IL160852A0 (en) Pharmaceutical compositions for the treatment of urinary disorders
EP1539100A4 (en) Composition and methods for the treatment of skin disorders
ZA200505996B (en) Combination therapy for the treatment of immunoinflammatory disorders
AU2003270540A8 (en) Treatment of cyclooxygenase-3 mediated diseases and disorders
GB0201025D0 (en) The treatment of degenerative diseases
GB0419828D0 (en) The treatment of inflammatroy disorders and pain
EP1677745A4 (en) Nitrone compounds prodrugs and pharmaceutical compositions of the same to treat human disorders

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060321

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20100122

17Q First examination report despatched

Effective date: 20100503

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110913